Strides Pharma Science’s flagship facility in Bangalore has received Form 483 with five observations from United States Food and Drug Administration (USFDA). The USFDA had conducted a routine current Good Manufacturing Practices (cGMP) inspection at the facility during the period from May 12, 2026 to May 20, 2026.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
